Mein Warenkorb

Glycoprotein D (HSV-1)

Glycoprotein D (HSV-1) Molekülinformation

Englischer NameEnvelope glycoprotein DAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1Target-Alias
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameEnvelope glycoprotein D
Target-Alias
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel1
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

Produktanfrage

Glycoprotein D (HSV-1) Molekülhintergrund

Herpesvirus infections are widely spread throughout the world population. Herpes simplex virus (HSV) belongs to the α-herpesvirus subfamily. There are two main types of HSV, HSV-1 and HSV-2, which infect humans. HSV-2 mainly causes genital lesions, whereas HSV-1 is involved in both oral and genital infections. Glycoprotein D (gD) is a structural component of the herpes simplex virus type 1 (HSV-1) envelope which is essential for virus entry and fusion with host cells. gD plays an important role by binding to the host receptors such as herpes virus entry mediator (HVEM) and nectin-1, a member of the immunoglobulin (Ig)-like cell adhesion molecules.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
UB-621UB-621Phase 2 ClinicalUnited Biopharma IncHerpes Simplex; Herpes Genitalis
Details
  • Molekülinformation
  • Produktanfrage
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns